Table 1.
Baseline Patients and Tumor Data
| Parameters | PVP+125I group | Radiotherapy group | p-Value |
|---|---|---|---|
| Average age | 61.14±5.21 | 59.83±6.61 | 0.342 |
| Gender | |||
| Male | 20 | 19 | 0.653 |
| Female | 30 | 31 | |
| Primary tumor | |||
| Colon | 1 | 2 | |
| Prostate | 10 | 11 | |
| Breast | 19 | 18 | 0.732 |
| Lung | 20 | 19 | |
| Number of vertebral lesions | |||
| 1 | 31 | 29 | |
| 2 | 17 | 18 | 0.625 |
| 3 | 2 | 3 | |
| Number of metastatic foci | |||
| Thoracic vertebra | 38 | 39 | 0.563 |
| Lumbar vertebra | 33 | 35 | |
| Average VAS | 8.73±0.31 | 8.34±0.56 | 0.882 |
| Average EORTC score | 61.23±3.21 | 61.70±4.14 | 0.431 |
PVP, percutaneous vertebroplasty; VAS, visual analogue pain scale; EORTC, European Organization for Research and Treatment of Cancer.